Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens

Treatment of multidrug resistant bacterial infections has been a great challenge globally. Previous studies including our study have highlighted the use of celecoxib, a non-steroidal anti-inflammatory drug in combination with antibiotic has decreased the minimal inhibitory concentration to limit Sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Annamanedi, Madhavi, Varma, Gajapati Y. N., Anuradha, K., Kalle, Arunasree M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420555/
https://www.ncbi.nlm.nih.gov/pubmed/28533769
http://dx.doi.org/10.3389/fmicb.2017.00805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420555/
https://www.ncbi.nlm.nih.gov/pubmed/28533769
http://dx.doi.org/10.3389/fmicb.2017.00805

Ejemplares similares